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Microbicides, which are products capable of reducing or
eliminating the risk of HIV-1 sexual transmission, are
urgently needed to combat the global spread of HIV-1.
Our efforts in this area are focused on the preclinical
development of the polybiguanide, PEHMB (polyethyl-
ene hexamethylene biguanide). PEHMB has been shown
to have low cytotoxicity both in vitro and in vivo, as well as
in vitro activity against both cell-free and cell-associated
forms of HIV-1. Flow cytometric analyses have shown that
PEHMB exposure results in epitope-specific alterations in
the detection of viral co-receptors CXCR4 and CCR5, sug-
gesting that PEHMB acts by interfering with events critical
to viral binding and entry. Changes in co-receptor detec-
tion have also been observed up to 24 hr after removal of
PEHMB. Consistent with the latter result was the demon-
stration of persistent protection from infection in experi-
ments in which cells were challenged with HIV-1 after
removal of PEHMB. Cumulatively, these results suggest
that HIV-1 co-receptors may play roles in PEHMB-medi-
ated protection from HIV-1 infection, and that products
containing PEHMB may provide both short- and long-
term protection against HIV-1 transmission.
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